Properties (67)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
government agency
|
| gptkbp:approves |
vaccines
new drugs |
| gptkbp:budget |
billions of dollars
|
| gptkbp:collaborates_with |
academic institutions
international organizations |
| gptkbp:conducts |
research
inspections |
| gptkbp:develops |
regulatory frameworks
|
| gptkbp:employs |
thousands of staff
|
| gptkbp:ensures |
public health
|
| gptkbp:established |
1906
|
| gptkbp:has |
regional offices
|
| gptkbp:has_a_mission_to |
protect public health
|
| gptkbp:has_a_role_in |
emergency response
biologics regulation health risk assessments nutrition labeling medical device innovation vaccine safety monitoring |
| gptkbp:hasAuthorityOver |
tobacco products
|
| gptkbp:headquarteredIn |
gptkb:Silver_Spring,_Maryland
|
| https://www.w3.org/2000/01/rdf-schema#label |
U.S. FDA
|
| gptkbp:is_involved_in |
public health campaigns
post-market surveillance foodborne illness investigations clinical trial oversight food safety modernization drug efficacy evaluation counterfeit drug prevention medical product safety medical product labeling. healthcare_technology_assessment orphan_drug_designation |
| gptkbp:is_known_for |
drug approval process
user fee programs fast track drug approval process |
| gptkbp:is_part_of |
gptkb:Department_of_Health_and_Human_Services
|
| gptkbp:issues |
guidelines
recalls safety communications warning letters import alerts guidance on clinical trial design approvals for clinical trials |
| gptkbp:monitors |
food labeling
|
| gptkbp:oversees |
clinical trials
|
| gptkbp:promotes |
public health initiatives
|
| gptkbp:provides |
training programs
technical assistance public access to information safety alerts consumer information guidance documents |
| gptkbp:regulates |
medical devices
pharmaceuticals food safety cosmetics dietary supplements blood products animal drugs infant formula |
| gptkbp:responsibleFor |
adverse event reporting
biologics license applications food additive approvals |
| gptkbp:works_with |
state agencies
drug shortages |